Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 11/20 | 0.54 |
| ▸ | CA2 | P00918 | 11/20 | 0.54 |
| ▸ | CA12 | O43570 | 5/20 | 0.54 |
| ▸ | CA9 | Q16790 | 5/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | NQO2 | P16083 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2587707 | 1.00 | CA1 (0.54) | CA1CA2CA12CA9TDP1 | |
| SCHEMBL382478 | 0.91 | NQO2 (0.51) | CA1CA2CA12CA9TDP1 | |
| SCHEMBL25263115 | 0.86 | CA1 (0.49) | CA1CA2CA12CA9NQO2 | |
| SCHEMBL21070849 | 0.86 | CA1 (0.49) | CA1CA2CA12CA9NQO2 | |
| SCHEMBL29040412 | 0.81 | CA1 (0.48) | CA1CA2CA12CA9TDP1 | |
| SCHEMBL597639 | 0.81 | CA1 (0.48) | CA1CA2CA12CA9TDP1 | |
| SCHEMBL28899596 | 0.81 | CA1 (0.48) | CA1CA2CA12CA9TDP1 | |
| SCHEMBL29040477 | 0.81 | CA1 (0.48) | CA1CA2CA12CA9TDP1 | |
| SCHEMBL29040418 | 0.81 | CA1 (0.48) | CA1CA2CA12CA9TDP1 | |
| SCHEMBL28468535 | 0.81 | CA1 (0.48) | CA1CA2CA12CA9TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2181093-A2 | IMMOBILIZATION OF DYES AND ANTIMICROBIAL AGENTS ON A MEDICAL DEVICE | BAXTER INTERNATIONAL INC. (US) | 2010-05-05 | — | — | EP | disclosed |
| WO-2009014997-A2 | IMMOBILIZATION OF DYES AND ANTIMICROBIAL AGENTS ON A MEDICAL DEVICE | BAXTER INTERNATIONAL INC. (US) | 2009-01-29 | — | — | WO | disclosed |
| US-20090024096-A1 | IMMOBILIZATION OF DYES AND ANTIMICROBIAL AGENTS ON A MEDICAL DEVICE | BAXTER INTERNATIONAL INC. (US) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090024096-A1 | IMMOBILIZATION OF DYES AND ANTIMICROBIAL AGENTS ON A MEDICAL DEVICE | CD99, CD44, ACR | CA1 833/4885CA2 3744/4885CA12 2455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.